Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
15,800
Employees15,800
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
15,800
Employees15,800

EW Key Statistics

Market cap
46.71B
Market cap46.71B
Price-Earnings ratio
34.95
Price-Earnings ratio34.95
Dividend yield
Dividend yield
Average volume
3.48M
Average volume3.48M
High today
$81.98
High today$81.98
Low today
$79.62
Low today$79.62
Open price
$81.50
Open price$81.50
Volume
6.46M
Volume6.46M
52 Week high
$87.89
52 Week high$87.89
52 Week low
$65.94
52 Week low$65.94

Stock Snapshot

The current Edwards Lifesciences(EW) stock price is $79.77, with a market capitalization of 46.71B. The stock trades at a price-to-earnings (P/E) ratio of 34.95.

On 2026-02-04, Edwards Lifesciences(EW) stock moved within a range of $79.62 to $81.98. With shares now at $79.77, the stock is trading +0.2% above its intraday low and -2.7% below the session's peak.

Trading volume for Edwards Lifesciences(EW) stock has reached 6.46M, versus its average volume of 3.48M.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $65.94.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $65.94.

EW News

TipRanks 7h
Edwards Lifesciences price target lowered to $94 from $95 at UBS

UBS analyst Danielle Antalffy lowered the firm’s price target on Edwards Lifesciences (EW) to $94 from $95 and keeps a Neutral rating on the shares. Published...

Simply Wall St 21h
How Edwards’ TAVR-First Pivot And JenaValve Exit At Edwards Lifesciences Has Changed Its Investment Story

In recent weeks, Edwards Lifesciences has drawn attention after exiting its planned JenaValve acquisition, raising 2026 EPS guidance, and emphasizing growth in...

How Edwards’ TAVR-First Pivot And JenaValve Exit At Edwards Lifesciences Has Changed Its Investment Story
Simply Wall St 3d
Has Edwards Lifesciences Price Slide Created A Fair Value Opportunity?

If you are wondering whether Edwards Lifesciences is offering good value at its current share price, this article will walk you through what the numbers are rea...

Has Edwards Lifesciences Price Slide Created A Fair Value Opportunity?

Analyst ratings

69%

of 35 ratings
Buy
68.6%
Hold
31.4%
Sell
0%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.